GO:1905324 telomere-telomerase complex assembly: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1905324 (telomere-telomerase complex assembly) is the biological process by which telomere and telomerase components aggregate, arrange and bond together to form a functional telomere-telomerase complex.
• The process is essential for telomere maintenance and genome stability, and its study bridges telomere biology, aging and cancer research.
• Key protein players include telomerase reverse transcriptase (TERT), telomerase RNA component (TERC), dyskerin (DKC1), NOP10, NHP2, GAR1, TCAB1 and the shelterin complex components.
• Dysregulation of telomere-telomerase complex assembly is linked to dyskeratosis congenita, aplastic anemia, pulmonary fibrosis and cancer.
• CRISPR knockout, point-mutation, knock-in and overexpression models are powerful tools to dissect the assembly process and its disease relevance.
• Advanced methods such as CRISPR library screening, proteomics and imaging are used to identify novel assembly factors and therapeutic targets.
Description
Telomere-telomerase complex assembly (GO:1905324) is the biological process in which a set of components aggregates, arranges and bonds together to form a telomere-telomerase complex. This process is fundamental for maintaining telomere length and protecting chromosome ends, thereby preserving genome integrity. Researchers study this term to understand how telomerase is recruited to telomeres and how defects in assembly contribute to human diseases such as dyskeratosis congenita and cancer. The assembly involves multiple steps, including the biogenesis of telomerase holoenzyme, its trafficking to the nucleus, and its interaction with telomere-binding proteins. Because telomere-telomerase complex assembly is a dynamic and multi-component process, it is a rich area for CRISPR-based functional genomics and drug discovery.
telomere-telomerase complex assembly At A Glance
| GO ID | GO:1905324 |
|---|---|
| GO term | telomere-telomerase complex assembly |
| Ontology | biological_process |
| Synonym | telomere-telomerase complex formation |
| Major function | Assembly of a functional telomere-telomerase complex for telomere maintenance |
| Key components | TERT, TERC, dyskerin, NOP10, NHP2, GAR1, TCAB1, shelterin proteins |
| Associated diseases | Dyskeratosis congenita, aplastic anemia, pulmonary fibrosis, cancer |
| Research methods | CRISPR knockout, point mutation, knock-in, overexpression, proteomics, imaging |
What Is GO:1905324?
According to the Gene Ontology, GO:1905324 (telomere-telomerase complex assembly) is defined as the aggregation, arrangement and bonding together of a set of components to form a telomere-telomerase complex. In other words, it encompasses all molecular events that bring together telomerase subunits, accessory factors and telomere-associated proteins to build a functional complex capable of elongating telomeres.
Why Is telomere-telomerase complex assembly Important in Cell Biology?
Understanding telomere-telomerase complex assembly is critical because defects in this process lead to telomere shortening, chromosomal instability and a spectrum of human diseases, including bone marrow failure syndromes and cancer. Moreover, telomerase is a prime target for anti-cancer therapies, and assembly factors are potential biomarkers and therapeutic targets.
• Maintains telomere length and chromosome stability.
• Prevents premature aging and age-related diseases.
• Its dysfunction causes dyskeratosis congenita and aplastic anemia.
• Telomerase activation is a hallmark of many cancers.
• Assembly factors are potential drug targets for cancer and degenerative diseases.
• CRISPR screens can identify novel assembly regulators.
• Provides insights into stem cell biology and tissue regeneration.
• Links telomere biology to immunoepigenetics and inflammation.
• Enables development of telomerase-based therapeutics.
• Facilitates understanding of RNA-protein complex assembly in general.
What Happens During telomere-telomerase complex assembly?
Telomerase holoenzyme biogenesis
In simple terms: The cell builds the telomerase enzyme by putting its RNA and protein parts together.
Telomerase holoenzyme biogenesis begins with the transcription of TERC and TERT, followed by the assembly of TERC with dyskerin, NOP10, NHP2 and GAR1 to form the H/ACA ribonucleoprotein core. This core is essential for TERC stability and telomerase activity.
Trafficking and localization
In simple terms: The assembled telomerase is moved to the right place in the cell, especially the nucleus.
After assembly, telomerase is trafficked to the nucleus and to telomeres, a process that requires TCAB1 and other accessory proteins. Proper localization ensures that telomerase can access chromosome ends.
Recruitment to telomeres
In simple terms: Telomerase is guided to the chromosome ends by telomere-binding proteins.
The shelterin complex, including TRF1, TRF2, POT1, TIN2, TPP1 and RAP1, binds telomeric DNA and recruits telomerase through interactions with TPP1 and POT1. This recruitment is a key step in telomere-telomerase complex assembly.
Complex stabilization and activation
In simple terms: Once at the telomere, the complex is stabilized and turned on to extend DNA.
The interaction between telomerase and shelterin components stabilizes the complex and stimulates telomerase activity, leading to telomere elongation. This step is regulated by phosphorylation and other post-translational modifications.
Key Genes Involved in GO:1905324 telomere-telomerase complex assembly
The following genes and proteins are central to telomere-telomerase complex assembly and are frequently studied in this context.
| Gene | Major Role | Research Relevance |
|---|---|---|
| TERT | Catalytic subunit of telomerase | Target for cancer and aging research |
| TERC | Telomerase RNA template | Mutations cause dyskeratosis congenita |
| DKC1 | Dyskerin, stabilizes TERC | Mutated in X-linked dyskeratosis congenita |
| NOP10 | H/ACA RNP component | Required for telomerase assembly |
| NHP2 | H/ACA RNP component | Essential for TERC stability |
| GAR1 | H/ACA RNP component | Facilitates telomerase biogenesis |
| TCAB1 | Telomerase trafficking | Mutations linked to dyskeratosis congenita |
| TRF1 | Shelterin component | Regulates telomere length |
| TRF2 | Shelterin component | Protects chromosome ends |
| POT1 | Shelterin component | Recruits telomerase |
| TIN2 | Shelterin component | Bridges shelterin subunits |
| TPP1 | Shelterin component | Activates telomerase |
| RAP1 | Shelterin component | Regulates telomere function |
| RTEL1 | Telomere maintenance | Helicase involved in replication |
| CTC1 | Telomere maintenance | Part of CST complex |
| STN1 | Telomere maintenance | CST complex subunit |
| TEN1 | Telomere maintenance | CST complex subunit |
How Is telomere-telomerase complex assembly Regulated?
Telomere-telomerase complex assembly is regulated at multiple levels, including transcription of TERT and TERC, post-translational modifications of telomerase subunits, and interactions with shelterin proteins. Additionally, epigenetic modifications and non-coding RNAs influence telomerase assembly and activity.
telomere-telomerase complex assembly and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DKC1 | Dyskeratosis congenita | Knockout cell model |
| TERC | Aplastic anemia | Point mutation knock-in |
| TERT | Pulmonary fibrosis | Overexpression model |
| TCAB1 | Dyskeratosis congenita | Knockout and rescue |
| TRF2 | Cancer and aging | Conditional knockout |
Dyskeratosis congenita and bone marrow failure
Mutations in genes encoding telomerase and shelterin components, such as DKC1, TERC, TERT, and TCAB1, impair telomere-telomerase complex assembly, leading to dyskeratosis congenita, aplastic anemia and pulmonary fibrosis.
Cancer
Telomerase is reactivated in most cancers, and assembly factors are often overexpressed, making them attractive targets for anti-cancer therapies.
Aging and degenerative diseases
Defective telomere-telomerase complex assembly contributes to premature aging syndromes and age-related degenerative diseases due to telomere shortening.
From telomere-telomerase complex assembly-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate telomerase assembly? | CRISPR knockout |
| What is the effect of a disease-associated point mutation? | Point mutation knock-in |
| How does a tag affect complex formation? | Tagged knock-in |
| Can overexpression rescue assembly defects? | Overexpression |
| Which genes are essential for assembly? | CRISPR library screening |
| What is the interactome of the complex? | Proteomics |
How to Study the telomere-telomerase complex assembly Process
| Method | What It Measures | Typical Application |
|---|---|---|
| CRISPR knockout | Gene function | Identify essential assembly genes |
| Point mutation knock-in | Effect of specific mutations | Model disease variants |
| Proteomics | Protein interactions | Map complex composition |
| Imaging | Localization and dynamics | Track assembly in live cells |
| RNA-seq | Gene expression | Measure transcriptional changes |
| Ribo-seq | Translation efficiency | Assess protein synthesis of assembly factors |
| CRISPR library screening | Fitness and phenotype | Discover novel regulators |
CRISPR knockout screening
Genome-wide CRISPR knockout screens can identify genes required for telomere-telomerase complex assembly and telomere maintenance.
Proteomics and interactomics
Affinity purification coupled with mass spectrometry reveals the protein composition and dynamic interactions within the telomere-telomerase complex.
Imaging and live-cell tracking
Fluorescence microscopy and live-cell imaging allow visualization of telomerase trafficking and assembly at telomeres.
RNA-seq and Ribo-seq
Transcriptomic and translatomic analyses measure expression changes in assembly factors under different conditions.
How CRISPR Can Be Used to Study GO:1905324 telomere-telomerase complex assembly
Knockout
CRISPR knockout of assembly genes such as DKC1 or TERC disrupts telomerase function and leads to telomere shortening, providing a model for dyskeratosis congenita.
Point Mutation
Introducing disease-associated point mutations (e.g., in TERT or TERC) via CRISPR allows precise modeling of impaired assembly and telomerase activity.
Knock-in
Tagged knock-in of telomerase subunits enables visualization and biochemical isolation of the complex for interaction studies.
Overexpression
Overexpression of TERT and TERC can enhance telomerase assembly and telomere elongation, useful for studying activation mechanisms.
How EDITGENE Supports telomere-telomerase complex assembly Research
Researchers studying telomere-telomerase complex assembly-related genes often need to determine whether a candidate gene is causally involved in the process, and CRISPR-based models are the gold standard for such functional validation.
Contact EDITGENE today to design your custom CRISPR model for telomere-telomerase complex assembly research.
Frequently Asked Questions About telomere-telomerase complex assembly
What is GO:1905324?
GO:1905324 is the Gene Ontology term for telomere-telomerase complex assembly, the process of forming a functional complex between telomerase and telomere components.
What genes are involved in telomere-telomerase complex assembly?
Key genes include TERT, TERC, DKC1, NOP10, NHP2, GAR1, TCAB1, and shelterin components like TRF1, TRF2, and POT1.
Why is telomere-telomerase complex assembly important?
It is essential for telomere maintenance, genome stability, and preventing diseases such as dyskeratosis congenita and cancer.
What diseases are linked to defects in this process?
Dyskeratosis congenita, aplastic anemia, pulmonary fibrosis, and certain cancers are associated with impaired assembly.
How can CRISPR be used to study this process?
CRISPR knockout, point mutation, knock-in, and overexpression models allow functional dissection of assembly genes and their roles in disease.
What methods are used to study telomere-telomerase complex assembly?
Common methods include CRISPR screening, proteomics, imaging, RNA-seq, and Ribo-seq.
What is the role of dyskerin in telomerase assembly?
Dyskerin (DKC1) stabilizes TERC and is essential for telomerase holoenzyme assembly; mutations cause dyskeratosis congenita.
How does the shelterin complex contribute to assembly?
Shelterin proteins bind telomeric DNA and recruit telomerase, facilitating complex assembly and activation.
Can telomerase assembly be targeted for cancer therapy?
Yes, inhibiting telomerase assembly is a promising anti-cancer strategy because most cancers rely on telomerase for immortalization.
What cell models are available for studying this term?
EDITGENE offers knockout, point mutation, knock-in, and overexpression cell models for genes in this pathway.
Conclusion
Telomere-telomerase complex assembly (GO:1905324) is a fundamental biological process that ensures telomere maintenance and genome stability. Its dysregulation underlies a range of human diseases, making it a key area for both basic and translational research. Leveraging CRISPR-based models and advanced screening technologies will continue to unravel the molecular details of this assembly and reveal new therapeutic opportunities.
References
- 1. Deng W et al.. 2026. Engineering yeast chromosomal telomeres with a bacteriophage system.. Nat Commun 17(1) PMID: 42151157
- 2. Melicher D et al.. 2015. Genetic and epigenetic trends in telomere research: a novel way in immunoepigenetics.. Cell Mol Life Sci 72(21):4095-109 PMID: 26190020
